Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005]
Sponsor: Children's Cancer and Leukaemia Group
Listed as NCT00379457, this PHASE3 trial focuses on Sarcoma and remains ongoing. Sponsored by Children's Cancer and Leukaemia Group, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jun 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Cancer and Leukaemia Group
- Dutch Childhood Oncology Group
- European Paediatric Soft Tissue Sarcoma Study Group
- Italian Association for Pediatric Hematology Oncology
For direct contact, visit the study record on ClinicalTrials.gov .